|
|
See Category: Neoplasms
See Header: Mantle cell lymphoma
ICD-10 (CM) Code and Descriptor
|
C83.17 |
Mantle cell lymphoma, spleen
|
C8317 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.42%
|
25.18%
|
8.57%
|
3.03%
|
1.33%
|
0.89%
|
0.96%
|
0.59%
|
0.37%
|
0.22%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C83.17*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
80053
|
COMPREHEN METABOLIC PANEL |
417
|
417
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
394
|
394
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
300
|
300
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
285
|
286
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
213
|
213
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
117
|
117
|
|
83735
|
ASSAY OF MAGNESIUM |
103
|
103
|
|
85027
|
COMPLETE CBC AUTOMATED |
81
|
81
|
|
84100
|
ASSAY OF PHOSPHORUS |
67
|
67
|
|
A9552
|
F18 FDG |
66
|
66
|
|
78815
|
PET IMAGE W/CT SKULL-THIGH |
60
|
60
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
52
|
2,246
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
50
|
2,186
|
|
85007
|
BL SMEAR W/DIFF WBC COUNT |
47
|
47
|
|
96413
|
CHEMO IV INFUSION 1 HR |
45
|
45
|
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
42
|
42
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
41
|
70
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
36
|
61
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
35
|
35
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
35
|
3,575
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C83.17 related to the following DRG Codes:
820-822
823-825
840-842
974-976
|
